NAD OKs 3 Of 15 Studies For Ameal BP Claims Substantiation
This article was originally published in The Tan Sheet
Executive Summary
Calpis USA should link claims for its ameal bp dietary supplement to only three of the 15 clinical trials it has cited as substantiation, the National Advertising Division says
You may also be interested in...
No Concealing Cosmeceutical Claims From NAD, FTC
Claims for cosmeceuticals referred by the National Advertising Division go to the same place on the Federal Trade Commission's list of priorities as other disputed claims - straight to the top
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement
Avoiding GMP “Showstoppers” Keeps Manufacturers Off FDA’s “Radar”
Compliance consultants warn that certain dietary supplement good manufacturing practices violations are inspection "showstoppers" and will draw agency enforcement